Perci Health has appointed Katie Crook-Davies as director of strategic accounts.
Crook-Davies (pictured) has more than 15 years’ experience across the UK protection industry.
A qualified life actuary, with experience at Swiss Re, Vitality and supporting various health technology companies, she most recently founded her own insurtech business Tabei.
The former co-chairwoman of the Income Protection Task Force (IPTF) has been a consistent advocate for improving access to protection products, enhancing customer outcomes, and leveraging digital and AI-driven innovation to support market growth, the firm said.
In her new role, she will lead on strategic account development, working closely with insurers, intermediaries, and employer partners to expand access to Perci’s end-to-end cancer care services and further embed its outcomes-based model across the market.
Crook-Davies said: “I’m delighted to be joining Perci Health at such a pivotal point in its journey. As cancer incidence continues to rise and survival rates improve, more people are living with and beyond cancer – creating a clear need to look beyond traditional insurance models.
“Perci Health’s approach recognises cancer as a complex, long-term condition that requires specialist, ongoing support.
“I’m excited to work with existing and new partners to help evolve propositions that better meet the needs of customers – supporting not just financial resilience, but real-world health and recovery outcomes.”
Morgan Fitzsimons, co-founder and CCO of Perci Health, added: “We are thrilled to welcome Katie to Perci Health. She brings a rare combination of actuarial expertise, strategic insight, and a deep understanding of the protection landscape.
“As cancer increasingly becomes a long-term condition, insurers and employers are recognising the need to go beyond traditional models and deliver more meaningful, ongoing support to their members.
“Katie’s experience and perspective will be instrumental in helping us scale our partnerships and continue to redefine what great cancer care looks like across the industry.”
